Top

Published in:

28-08-2021 | Acute Kidney Injury | Review

Kidney implications of SARS-CoV2 infection in children

Authors: Erica C. Bjornstad, Michael E. Seifert, Keia Sanderson, Daniel I. Feig

Published in: Pediatric Nephrology | Issue 7/2022

Abstract

Research indicates that severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection can impact every organ, and the effects can range from asymptomatic to severe disease. Since it was first discovered in December 2019, our understanding has grown about its impact on kidney disease. In general, children have less severe disease than adults, and this tendency appears to extend to special pediatric kidney populations (e.g., chronic kidney disease and immunosuppressed patients with solid organ transplants or nephrotic syndrome). However, in a fraction of infected children, SARS-CoV2 causes an array of kidney manifestations, ranging from acute kidney injury to thrombotic microangiopathy, with potential implications for increased risk of morbidity and mortality. Additional considerations surround the propensity for clotting extracorporeal circuits in children with SARS-CoV2 infection that are receiving kidney replacement therapy. This review provides an update on our current understanding of SARS-CoV2 for pediatric nephrologists and highlights knowledge gaps to be addressed by future research during this ongoing pandemic, particularly the social disparities magnified during this period.

Hussain A, Hasan A, Nejadi Babadaei MM et al (2020) Targeting SARS-CoV2 spike protein receptor binding domain by therapeutic antibodies. Biomed Pharmacother 130:1–10. https://doi.org/10.1016/j.biopha.2020.110559CrossRef

Wiersinga WJ, Rhodes A, Cheng AC et al (2020) Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 324:782–793. https://doi.org/10.1001/jama.2020.12839CrossRefPubMed

Bjornstad EC, Krallman KA, Askenazi D et al (2020) Preliminary assessment of acute kidney injury in critically ill children associated with SARS-CoV-2 infection. Clin J Am Soc Nephrol 16:446–448. https://doi.org/10.2215/cjn.11470720CrossRefPubMedPubMedCentral

Al-Aly Z, Xie Y, Bowe B (2021) High-dimensional characterization of post-acute sequalae of COVID-19. Nature 594:259–264. https://doi.org/10.1038/s41586-021-03553-9CrossRefPubMed

Hoffmann M, Kleine-Weber H, Schroeder S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271-280.e8. https://doi.org/10.1016/j.cell.2020.02.052CrossRefPubMedPubMedCentral

Salamanna F, Maglio M, Landini MP, Fini M (2020) Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2. Front Med 7:594495. https://doi.org/10.3389/fmed.2020.594495CrossRef

Pan XW, Xu D, Zhang H et al (2020) Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med 46:1114–1116. https://doi.org/10.1007/s00134-020-06026-1CrossRefPubMedPubMedCentral

Simões e Silva AC, Lanza K, Palmeira VA et al (2020) 2020 update on the renin–angiotensin–aldosterone system in pediatric kidney disease and its interactions with coronavirus. Pediatr Nephrol 36:1407–1426. https://doi.org/10.1007/s00467-020-04759-1CrossRefPubMedPubMedCentral

Centers for Disease Control and Prevention Health Alert Network (2020) Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19). https://emergency.cdc.gov/han/2020/han00432.asp. Accessed 14 May 2021

10.

Morris SB, Schwartz NG, Patel P et al (2020) Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection — United Kingdom and United States. MMWR Morb Mortal Wkly Rep 69:1450–1456. https://doi.org/10.15585/mmwr.mm6940e1CrossRefPubMedPubMedCentral

11.

Royal College of Paediatrics and Child Health (2020) Paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS) - guidance for clinicians. https://www.rcpch.ac.uk/resources/paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19-pims-guidance. Accessed 14 May 2021

12.

World Health Organization (2020) Multisystem inflammatory syndrome in children and adolescents with COVID-19: Scientific Brief. https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19. Accessed 13 May 2021

13.

Patel A, Abdulaal A, Ariyanayagam D et al (2020) Investigating the association between ethnicity and health outcomes in SARS-CoV-2 in a London secondary care population. PLoS ONE 15:e0240960. https://doi.org/10.1371/journal.pone.0240960CrossRefPubMedPubMedCentral

14.

García-Salido A, de Carlos Vicente JC, Belda Hofheinz S et al (2020) Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain. Crit Care 24:666. https://doi.org/10.1186/s13054-020-03332-4CrossRefPubMedPubMedCentral

15.

Gabarre P, Dumas G, Dupont T et al (2020) Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med 46:1339–1348. https://doi.org/10.1007/s00134-020-06153-9CrossRefPubMedPubMedCentral

16.

Moledina DG, Simonov M, Yamamoto Y et al (2021) The Association of COVID-19 with acute kidney injury independent of severity of illness: a multicenter cohort study. Am J Kidney Dis 77:490-499.e1. https://doi.org/10.1053/j.ajkd.2020.12.007CrossRefPubMedPubMedCentral

17.

Stewart DJ, Hartley JC, Johnson M et al (2020) Renal dysfunction in hospitalised children with COVID-19. Lancet Child Adolesc Health 4:e28–e29. https://doi.org/10.1016/S2352-4642(20)30178-4CrossRefPubMedPubMedCentral

18.

Verma S, Lumba R, Dapul HM et al (2021) Characteristics of hospitalized children with SARS-CoV-2 in the New York City metropolitan area. Hosp Pediatr 11:71–78. https://doi.org/10.1542/hpeds.2020-001917CrossRefPubMed

19.

Neugarten J, Bellin E, Yunes M et al (2020) AKI in hospitalized patients with and without COVID-19: a comparison study. J Am Soc Nephrol 31:2145–2157. https://doi.org/10.1681/ASN.2020040509CrossRefPubMedPubMedCentral

20.

Cheng Y, Luo R, Wang K et al (2020) Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 97:829–838. https://doi.org/10.1016/j.kint.2020.03.005CrossRefPubMedPubMedCentral

21.

Ng JH, Hirsch JS, Hazzan A et al (2021) Outcomes among patients hospitalized with COVID-19 and acute kidney injury. Am J Kidney Dis 77:204-215.e1. https://doi.org/10.1053/j.ajkd.2020.09.002CrossRefPubMed

22.

Nadim MK, Forni LG, Mehta RL et al (2020) COVID-19-associated acute kidney injury: consensus report of the 25th acute disease quality Initiative (ADQI) Workgroup. Nat Rev Nephrol 16:747–764. https://doi.org/10.1038/s41581-020-00356-5CrossRefPubMedPubMedCentral

23.

Rudd KE, Cizmeci EA, Galli GM et al (2021) Pragmatic recommendations for the prevention and treatment of acute kidney injury in patients with COVID-19 in low- and middle-income countries. Am J Trop Med Hyg 104:87–98. https://doi.org/10.4269/ajtmh.20-1242CrossRefPubMedPubMedCentral

24.

Deep A, Bansal M, Ricci Z (2020) Acute kidney injury and special considerations during renal replacement therapy in children with coronavirus disease-19: perspective from the critical care nephrology section of the European Society of Paediatric and Neonatal Intensive Care. Blood Purif 50:150–160. https://doi.org/10.1159/000509677CrossRefPubMed

25.

Alabbas A, Kirpalani A, Morgan C et al (2021) Canadian Association of Paediatric Nephrologists COVID-19 rapid response: guidelines for management of acute kidney injury in children. Can J Kidney Health Dis 8:2054358121990135. https://doi.org/10.1177/2054358121990135CrossRefPubMedPubMedCentral

26.

Chua HR, MacLaren G, Choong LHL et al (2020) Ensuring sustainability of continuous kidney replacement therapy in the face of extraordinary demand: lessons from the COVID-19 pandemic. Am J Kidney Dis 76:392–400. https://doi.org/10.1053/j.ajkd.2020.05.008CrossRefPubMedPubMedCentral

27.

McCulloch M, Abugrain K, Mosalakatane T et al (2020) Peritoneal dialysis for treatment of acute kidney injury in a case of paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. Perit Dial Int 40:515–517. https://doi.org/10.1177/0896860820953716CrossRefPubMed

28.

Lipton M, Kavanagh CR, Mahajan R et al (2020) Role of pediatric nephrologists in managing adults with AKI due to COVID-19. Pediatr Nephrol 35:2019–2022. https://doi.org/10.1007/s00467-020-04680-7CrossRefPubMedPubMedCentral

29.

Xie B, Zhang J, Li Y et al (2021) COVID-19: imbalanced immune responses and potential immunotherapies. Front Immunol 11:607583. https://doi.org/10.3389/fimmu.2020.607583CrossRefPubMedPubMedCentral

30.

Faqihi F, Alharthy A, Abdulaziz S et al (2021) Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomized control clinical trial. Int J Antimicrob Agents 57:106334. https://doi.org/10.1016/j.ijantimicag.2021.106334CrossRefPubMedPubMedCentral

31.

Emeksiz S, Özcan S, Perk O et al (2021) Therapeutic plasma exchange: a potential management strategy for critically ill MIS-C patients in the pediatric intensive care unit. Transfus Apher Sci 60:103119. https://doi.org/10.1016/j.transci.2021.103119CrossRefPubMed

32.

Chaijamorn W, Rungkitwattanakul D, Nuchtavorn N et al (2020) Antiviral dosing modification for coronavirus disease 2019–infected patients receiving extracorporeal therapy. Crit Care Explor 2:e0242. https://doi.org/10.1097/cce.0000000000000242CrossRefPubMedPubMedCentral

33.

Henry BM, Benoit SW, de Oliveira MHS et al (2020) ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID-19: evidence of SARS-CoV-2 induced secondary thrombotic microangiopathy. Int J Lab Hematol 43(Suppl 1):129–136. https://doi.org/10.1111/ijlh.13415CrossRefPubMed

34.

Lavinio A, Ercole A, Battaglini D et al (2021) Safety profile of enhanced thromboprophylaxis strategies for critically ill COVID-19 patients during the first wave of the pandemic: observational report from 28 European intensive care units. Crit Care 25:155. https://doi.org/10.1186/s13054-021-03543-3CrossRefPubMedPubMedCentral

35.

Tassiopoulos AK, Mofakham S, Rubano JA et al (2021) D-Dimer-driven anticoagulation reduces mortality in intubated COVID-19 patients: a cohort study with a propensity-matched analysis. Front Med 8:631335. https://doi.org/10.3389/fmed.2021.631335CrossRef

36.

Diorio C, McNerney KO, Lambert M et al (2020) Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Adv 4:6051–6063. https://doi.org/10.1182/bloodadvances.2020003471CrossRefPubMedPubMedCentral

37.

Akilesh S, Nast CC, Yamashita M et al (2021) Multicenter clinicopathologic correlation of kidney biopsies performed in COVID-19 patients presenting with acute kidney injury or proteinuria. Am J Kidney Dis 77:82-93.e1. https://doi.org/10.1053/j.ajkd.2020.10.001CrossRefPubMed

38.

Shah SA, Carter HP (2020) New-onset nephrotic syndrome in a child associated with COVID-19 infection. Front Pediatr 8:471. https://doi.org/10.3389/fped.2020.00471CrossRefPubMedPubMedCentral

39.

Alvarado A, Franceschi G, Resplandor E et al (2021) COVID-19 associated with onset nephrotic syndrome in a pediatric patient: coincidence or related conditions? Pediatr Nephrol 36:205–207. https://doi.org/10.1007/s00467-020-04724-yCrossRefPubMed

40.

Novelli L, Motta F, De Santis M et al (2021) The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 – a systematic review of the literature. J Autoimmun 117:102592. https://doi.org/10.1016/j.jaut.2020.102592CrossRefPubMed

41.

Ahmed S, Zimba O, Gasparyan AY (2021) COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol 40:2611–2619. https://doi.org/10.1007/s10067-021-05691-xCrossRefPubMedPubMedCentral

42.

Azzi Y, Bartash R, Scalea J et al (2021) COVID-19 and solid organ transplantation: a review article. Transplantation 105:37–55. https://doi.org/10.1097/TP.0000000000003523CrossRefPubMed

43.

Charnaya O, Chiang TPY, Wang R et al (2021) Effects of COVID-19 pandemic on pediatric kidney transplant in the United States. Pediatr Nephrol 36:143–151. https://doi.org/10.1007/s00467-020-04764-4CrossRefPubMed

44.

Akalin E, Azzi Y, Bartash R et al (2020) Covid-19 and kidney transplantation. N Engl J Med 382:2475–2477. https://doi.org/10.1056/nejmc2011117CrossRefPubMed

45.

Marinaki S, Tsiakas S, Korogiannou M et al (2020) A systematic review of COVID-19 infection in kidney transplant recipients: a universal effort to preserve patients’ lives and allografts. J Clin Med 9:2986. https://doi.org/10.3390/jcm9092986CrossRefPubMedCentral

46.

Varnell C, Harshman LA, Smith L et al (2021) COVID-19 in pediatric kidney transplantation: the improving renal outcomes collaborative. Am J Transplant. https://doi.org/10.1111/ajt.16501CrossRefPubMedPubMedCentral

47.

Teoh CW, Gaudreault-Tremblay MM, Blydt-Hansen TD et al (2020) Management of pediatric kidney transplant patients during the COVID-19 pandemic: guidance from the Canadian Society of Transplantation Pediatric Group. Can J Kidney Health Dis 7:2054358120967845. https://doi.org/10.1177/2054358120967845CrossRefPubMedPubMedCentral

48.

Waldman M, Soler MJ, García-Carro C et al (2021) Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring. Kidney Int 99:227–237. https://doi.org/10.1016/j.kint.2020.10.032CrossRefPubMed

49.

Perlin DV, Dymkov IN, Terentiev AV, Perlina AV (2021) Is kidney transplantation from a COVID-19–positive deceased donor safe for the recipient? Transplant Proc 53:1138–1142. https://doi.org/10.1016/j.transproceed.2021.01.025CrossRefPubMedPubMedCentral

50.

Yoshinaga K, Araki M, Wada K et al (2021) Successful deceased donor kidney transplantation to a recipient with a history of COVID-19 treatment. J Infect Chemother 27:1097–1101. https://doi.org/10.1016/j.jiac.2021.03.018CrossRefPubMedPubMedCentral

51.

Alshami A, Al Attas R, Azzam A et al (2021) Detection of SARS-CoV-2 antibodies in pediatric kidney transplant patients. BMC Nephrol 22:123. https://doi.org/10.1186/s12882-021-02325-xCrossRefPubMedPubMedCentral

52.

Ikizler TA, Coates PT, Rovin BH, Ronco P (2021) Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy. Kidney Int 99:1275–1279. https://doi.org/10.1016/j.kint.2021.04.007CrossRefPubMedPubMedCentral

53.

Marlais M, Wlodkowski T, Al-Akash S et al (2020) COVID-19 in children treated with immunosuppressive medication for kidney diseases. Arch Dis Child. https://doi.org/10.1136/archdischild-2020-320616CrossRefPubMed

54.

Espinosa G, Prieto-González S, Llevadot M et al (2021) The impact of SARS-CoV-2 coronavirus infection in patients with systemic lupus erythematosus from a single center in Catalonia. Clin Rheumatol 40:2057–2063. https://doi.org/10.1007/s10067-021-05675-xCrossRefPubMedPubMedCentral

55.

American College of Rheumatology COVID-19 Vaccine Clinical Guidance Task Force (2021) COVID-19 vaccine clinical guidance summary for patients with rheumatic and musculoskeletal diseases. https://www.rheumatology.org/Portals/0/Files/COVID-19-Vaccine-Clinical-Guidance-Rheumatic-Diseases-Summary.pdf. Accessed 21 May 2021

56.

Akbarialiabad H, Kavousi S, Ghahramani A et al (2020) COVID-19 and maintenance hemodialysis: a systematic scoping review of practice guidelines. BMC Nephrol 21:470. https://doi.org/10.1186/s12882-020-02143-7CrossRefPubMedPubMedCentral

57.

Chen C-Y, Shao S-C, Chen Y-T et al (2021) Incidence and clinical impacts of COVID-19 infection in patients with hemodialysis: systematic review and meta-analysis of 396,062 hemodialysis patients. Healthcare (Basel) 9:47. https://doi.org/10.3390/healthcare9010047CrossRef

58.

Mastrangelo A, Morello W, Vidal E et al (2021) Impact of covid-19 pandemic in children with CKD or immunosuppression. Clin J Am Soc Nephrol 16:449–451. https://doi.org/10.2215/CJN.13120820CrossRefPubMed

59.

Yau K, Muller MP, Lin M et al (2020) COVID-19 outbreak in an urban hemodialysis unit. Am J Kidney Dis 76:690-695.e1. https://doi.org/10.1053/j.ajkd.2020.07.001CrossRefPubMedPubMedCentral

60.

Centers for Disease Control and Prevention (2020) Interim additional guidance for infection prevention and control recommendations for patients with suspected or confirmed COVID-19 in outpatient hemodialysis facilities. https://www.cdc.gov/coronavirus/2019-ncov/hcp/dialysis.html. Accessed 14 May 2021

61.

Basile C, Combe C, Pizzarelli F et al (2020) Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres. Nephrol Dial Transplant 35:737–741. https://doi.org/10.1093/ndt/gfaa069CrossRefPubMed

62.

Prasad N, Kumar Agarwal S, Sahay M et al (2021) Indian Society of Nephrology - COVID-19 Working Group Guidelines. https://isn-india.org/UserFiles/Image/COVID-19 working group of ISN India.pdf. Accessed 14 May 2021

63.

Shen Q, Wang M, Che R et al (2020) Consensus recommendations for the care of children receiving chronic dialysis in association with the COVID-19 epidemic. Pediatr Nephrol 35:1351–1357. https://doi.org/10.1007/s00467-020-04555-xCrossRefPubMedPubMedCentral

64.

Dudreuilh C, Roper T, Breen C et al (2021) IgG SARS-CoV-2 antibodies persist at least for 10 months in patients on hemodialysis. Kidney Int Rep 6:1961–1964. https://doi.org/10.1016/j.ekir.2021.03.900CrossRefPubMedPubMedCentral

65.

Grupper A, Sharon N, Finn T et al (2021) Humoral response to the Pfizer BNT162b2 vaccine in patients undergoing maintenance hemodialysis. Clin J Am Soc Nephrol. https://doi.org/10.2215/cjn.03500321CrossRefPubMed

66.

Lim JH, Jung HY, Choi JY et al (2020) Hypertension and electrolyte disorders in patients with COVID-19. Electrolyte Blood Press 18:23–30. https://doi.org/10.5049/EBP.2020.18.2.23CrossRefPubMedPubMedCentral

67.

Cohen JB, South AM, Shaltout HA et al (2021) Renin–angiotensin system blockade in the COVID-19 pandemic. Clin Kidney J 14:i48–i59. https://doi.org/10.1093/ckj/sfab026CrossRefPubMedPubMedCentral

68.

Wang Y, Chen B, Li Y et al (2021) The use of renin–angiotensin–aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: a systematic review and meta-analysis. J Med Virol 93:1370–1377. https://doi.org/10.1002/jmv.26625CrossRefPubMed

69.

Semenzato L, Botton J, Drouin J et al (2021) Antihypertensive drugs and COVID-19 risk: a cohort study of 2 million hypertensive patients. Hypertension 77:833–842. https://doi.org/10.1161/HYPERTENSIONAHA.120.16314CrossRefPubMed

70.

Adamsick ML, Gandhi RG, Bidell MR et al (2020) Remdesivir in patients with acute or chronic kidney disease and COVID-19. J Am Soc Nephrol 31:1384–1386. https://doi.org/10.1681/ASN.2020050589CrossRefPubMedPubMedCentral

71.

Wang Y, Zhang D, Du G et al (2020) Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 395:1569–1578. https://doi.org/10.1016/S0140-6736(20)31022-9CrossRefPubMedPubMedCentral

72.

Laar SA, Boer MGJ, Gombert-Handoko KB et al (2021) Liver and kidney function in patients with Covid-19 treated with remdesivir. Br J Clin Pharmacol. https://doi.org/10.1111/bcp.14831CrossRefPubMed

73.

Xu Z, Tang Y, Huang Q et al (2021) Systematic review and subgroup analysis of the incidence of acute kidney injury (AKI) in patients with COVID-19. BMC Nephrol 22:52. https://doi.org/10.1186/s12882-021-02244-xCrossRefPubMedPubMedCentral

74.

Basalely A, Gurusinghe S, Schneider J et al (2021) Acute kidney injury in pediatric patients hospitalized with acute COVID-19 and multisystem inflammatory syndrome in children associated with COVID-19. Kidney Int 100:138–145. https://doi.org/10.1016/j.kint.2021.02.026CrossRefPubMedPubMedCentral

75.

Raisi-Estabragh Z, McCracken C, Bethell MS et al (2020) Greater risk of severe COVID-19 in Black, Asian and minority ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1326 cases from the UK Biobank. J Public Health (Oxf) 42:451–460. https://doi.org/10.1093/pubmed/fdaa095CrossRef

76.

Melchior M, Desgrées du Loû A, Gosselin A et al (2021) Migrant status, ethnicity and COVID-19: more accurate European data are greatly needed. Clin Microbiol Infect 27:160–162. https://doi.org/10.1016/j.cmi.2020.10.014CrossRefPubMed

77.

Tan IB, Tan C, Hsu LY et al (2021) Prevalence and outcomes of SARS-CoV-2 Infection among Migrant Workers in Singapore. JAMA 325:584–585. https://doi.org/10.1001/jama.2020.24071CrossRefPubMedPubMedCentral

78.

Kabarriti R, Brodin NP, Maron MI et al (2020) Association of race and ethnicity with comorbidities and survival among patients with COVID-19 at an urban medical center in New York. JAMA Netw Open 3:e2019795. https://doi.org/10.1001/jamanetworkopen.2020.19795CrossRefPubMedPubMedCentral

79.

Yehia BR, Winegar A, Fogel R et al (2020) Association of race with mortality among patients hospitalized with coronavirus disease 2019 (COVID-19) at 92 US hospitals. JAMA Netw Open 3:e2018039. https://doi.org/10.1001/jamanetworkopen.2020.18039CrossRefPubMedPubMedCentral

80.

Xu JJ, Chen JT, Belin TR et al (2021) Racial and ethnic disparities in years of potential life lost attributable to covid-19 in the united states: an analysis of 45 states and the District of Columbia. Int J Environ Res Public Health 18:2921. https://doi.org/10.3390/ijerph18062921CrossRefPubMedPubMedCentral

81.

Lee EH, Kepler KL, Geevarughese A et al (2020) Race/ethnicity among children with COVID-19-associated multisystem inflammatory syndrome. JAMA Netw Open 3:e2030280. https://doi.org/10.1001/jamanetworkopen.2020.30280CrossRefPubMedPubMedCentral

82.

Adler AC, Shah AS, Blumberg TJ et al (2021) Symptomatology and racial disparities among children undergoing universal preoperative COVID-19 screening at three US children’s hospitals: early pandemic through resurgence. Paediatr Anaesth 31:368–371. https://doi.org/10.1111/pan.14074CrossRefPubMed

83.

Dyke MEV, Mendoza MCB, Li W et al (2021) Racial and ethnic disparities in COVID-19 incidence by age, sex, and period among persons aged <25 years 16 US Jurisdictions. MMWR Morb Mortal Wkly Rep. 70:382–388. https://doi.org/10.15585/mmwr.mm7011e1

84.

Labgold K, Hamid S, Shah S et al (2021) Estimating the unknown: greater racial and ethnic disparities in COVID-19 burden after accounting for missing race and ethnicity data. Epidemiology 32:157–161. https://doi.org/10.1097/EDE.0000000000001314CrossRefPubMedPubMedCentral

85.

Kim D, Lee Y, Thorsness R et al (2021) Racial and ethnic disparities in excess deaths among persons with kidney failure during the COVID-19 pandemic, March-July 2020. Am J Kidney Dis 77:827–829. https://doi.org/10.1053/j.ajkd.2021.02.003CrossRefPubMedPubMedCentral

86.

Nguyen LH, Joshi AD, Drew DA et al (2021) Racial and ethnic differences in COVID-19 vaccine hesitancy and uptake. Preprint. https://doi.org/10.1101/2021.02.25.21252402

87.

Strully KW, Harrison TM, Pardo TA, Carleo-Evangelist J (2021) Strategies to address COVID-19 vaccine hesitancy and mitigate health disparities in minority populations. Front Public Health 9:645268. https://doi.org/10.3389/fpubh.2021.645268CrossRefPubMedPubMedCentral

88.

Quinn SC, Jamison A, Freimuth VS et al (2017) Exploring racial influences on flu vaccine attitudes and behavior: results of a national survey of White and African American adults. Vaccine 35:1167–1174. https://doi.org/10.1016/j.vaccine.2016.12.046CrossRefPubMedPubMedCentral

89.

Taylor S, Landry CA, Paluszek MM et al (2020) A proactive approach for managing COVID-19: the importance of understanding the motivational roots of vaccination fesitancy for SARS-CoV2. Front Psychol 11:575950. https://doi.org/10.3389/fpsyg.2020.575950CrossRefPubMedPubMedCentral

90.

Holder J (2021) Tracking coronavirus vaccinations around the world. New York Times. https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html. Accessed 5 Jul 2021

91.

Beigel JH, Tomashek KM, Dodd LE et al (2020) Remdesivir for the treatment of Covid-19 - final report. N Engl J Med 383:1813–1826. https://doi.org/10.1056/nejmoa2007764CrossRefPubMed

92.

RECOVERY Collaborative Group; Horby P, Lim WS, Emberson JR et al (2021) Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 384:693–704. https://doi.org/10.1056/nejmoa2021436

93.

WHO Solidarity Trial Consortium; Pan H, Peto R, Henao-Restrepo A et al (2021) Repurposed antiviral drugs for Covid-19 – interim WHO solidarity trial results. N Engl J Med 384:497–511. https://doi.org/10.1056/nejmoa2023184

94.

National Institutes of Health (2021) Coronavirus disease 2019 (COVID-19) treatment guidelines. https://www.covid19treatmentguidelines.nih.gov/. Accessed 21 May 2021

95.

Feldstein LR, Tenforde MW, Friedman KG et al (2021) Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA 325:1074–1087. https://doi.org/10.1001/jama.2021.2091CrossRefPubMed

96.

Davies P, Evans C, Kanthimathinathan HK et al (2020) Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc Health 4:669–677. https://doi.org/10.1016/S2352-4642(20)30215-7CrossRefPubMedPubMedCentral

Title: Kidney implications of SARS-CoV2 infection in children
Authors: Erica C. Bjornstad
Michael E. Seifert
Keia Sanderson
Daniel I. Feig
Publication date: 28-08-2021
Publisher: Springer Berlin Heidelberg
Keywords: Acute Kidney Injury
SARS-CoV-2
COVID-19
Chronic Kidney Disease
Acute Kidney Injury
Published in: Pediatric Nephrology / Issue 7/2022
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-021-05249-8

At a glance: The STEP trials

Springer Medicine

Kidney implications of SARS-CoV2 infection in children

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2022

Two patients presenting IgA nephropathy after COVID-19 vaccination during a follow-up for asymptomatic hematuria

Determinants of medication adherence in childhood nephrotic syndrome and associations of adherence with clinical outcomes

Systematic review of atypical hemolytic uremic syndrome biomarkers

IgA nephropathy following COVID-19 vaccination: challenges and perspectives

Low albumin levels are independently associated with neonatal acute kidney injury: a report from AWAKEN Study Group

Clinical and neurophysiological characterization of early neuromuscular involvement in children and adolescents with nephropathic cystinosis